Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 155.00 INR
Change Today 0.00 / 0.00%
Volume 0.0
TMCH On Other Exchanges
Symbol
Exchange
Natl India
As of 7:06 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

themis medicare ltd (TMCH) Snapshot

Open
152.05
Previous Close
155.00
Day High
156.00
Day Low
152.05
52 Week High
12/8/14 - 217.90
52 Week Low
07/10/14 - 95.05
Market Cap
1.3B
Average Volume 10 Days
3.6K
EPS TTM
5.91
Shares Outstanding
8.5M
EX-Date
07/20/11
P/E TM
26.2x
Dividend
--
Dividend Yield
--
Current Stock Chart for THEMIS MEDICARE LTD (TMCH)

Related News

No related news articles were found.

themis medicare ltd (TMCH) Related Businessweek News

No Related Businessweek News Found

themis medicare ltd (TMCH) Details

Themis Medicare Limited manufactures and markets pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients; and formulations for use in various therapeutic areas, such as antituberculosis, antimalarial, cardiology, pain management, anti-infectives, haematinics, and health and nutrition. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was founded in 1969 and is headquartered in Mumbai, India.

Founded in 1969

themis medicare ltd (TMCH) Top Compensated Officers

Chief Executive Officer, Managing Director, M...
Total Annual Compensation: 4.9M
Member of Executive Management Board, Deputy ...
Total Annual Compensation: 4.8M
Compensation as of Fiscal Year 2014.

themis medicare ltd (TMCH) Key Developments

Themis Medicare Ltd. Reports Audited Standalone Earnings Results for the Fourth Quarter and Audited Standalone and Consolidated Earnings Results for the Full Year Ended March 31, 2015

Themis Medicare Ltd. reported audited standalone earnings results for the fourth quarter and audited standalone and consolidated earnings results for the full year ended March 31, 2015. For the quarter, on standalone basis, the company reported net sales/income from operations (net of excise duty) of INR 408.358 million compared to INR 306.979 million a year ago. Profit from operations before other income, financial costs & exceptional items was INR 25.230 million compared to INR 11.287 million a year ago. Profit from ordinary activities before tax was INR 0.391 million compared to loss of INR 2.306 million a year ago. Net profit was INR 3.911 million or INR 0.44 per diluted share before and after extraordinary items compared to INR 0.615 million or INR 0.07 per diluted share before and after extraordinary items for the same period a year ago. For the year, on standalone basis, the company reported net sales/income from operations (net of excise duty) of INR 1,659.481 million compared to INR 1,668.481 a year ago. Profit from operations before other income, financial costs & exceptional items was INR 35.761 million compared to INR 127.013 million a year ago. Profit from ordinary activities before tax was INR 15.756 million compared to INR 11.418 million a year ago. Net profit was INR 20.450 million or INR 2.31 per diluted share before and after extraordinary items compared to INR 15.311 million or INR 1.73 per diluted share before and after extraordinary items for the same period a year ago. For the year, on consolidated basis, the company reported net sales/income from operations (net of excise duty) of INR 1,997.275 million compared to INR 1,894.494 a year ago. Profit from operations before other income, financial costs & exceptional items was INR 78.757 million compared to INR 147.076 million a year ago. Profit from ordinary activities before tax was INR 60.034 million compared to INR 39.782 million a year ago. Net profit was INR 42.320 million or INR 5.65 per diluted share before and after extraordinary items compared to INR 26.962 million or INR 3.05 per diluted share before and after extraordinary items for the same period a year ago.

Themis Medicare Ltd, Board Meeting, May 27, 2015

Themis Medicare Ltd, Board Meeting, May 27, 2015. Agenda: To consider audited results; to consider formulated and adopted code of practices and procedures for fair disclosure of unpublished price sensitive information of the company; and to formulate code of conduct for prohibition of insider trading of the company.

Themis Medicare Ltd Announces Board Changes

Themis Medicare Ltd. at the board of directors meeting held on March 17, 2015, accepted resignation of Dr. Gabor Gulasei as an alternate director to Dr. Laszlo Kovacs and the company has appointed Mrs. Jayashree D.Patel as an alternate director to Dr. Laszlo Kovacs.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TMCH:IN 155.00 INR 0.00

TMCH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TMCH.
View Industry Companies
 

Industry Analysis

TMCH

Industry Average

Valuation TMCH Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THEMIS MEDICARE LTD, please visit www.themismedicare.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.